These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ureteritis due to cytomegalovirus infection in renal transplant recipient: a case report. Vongwiwatana A; Vareesangthip K; Vasuvattakul S; Prommol S; Nualyong C; Parichatikanond P; Ong-Aj-Yooth L; Nimmannit S Transplant Proc; 2000 Nov; 32(7):1927. PubMed ID: 11120004 [No Abstract] [Full Text] [Related]
6. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation. Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354 [TBL] [Abstract][Full Text] [Related]
7. Treatment of transplant rejection in the presence of cytomegalovirus viremia. O'Hair DP; Johnson CP; Roza AM; Adams MB Transplant Proc; 1990 Aug; 22(4):1815-7. PubMed ID: 2167537 [No Abstract] [Full Text] [Related]
8. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial. Sterneck M; Fischer L; Gahlemann C; Gundlach M; Rogiers X; Broelsch C Ann Transplant; 2000; 5(1):43-6. PubMed ID: 10850611 [TBL] [Abstract][Full Text] [Related]
9. Successful management of symptomatic cytomegalovirus disease with ganciclovir after heart transplantation. Cooper DK; Novitzky D; Schlegel V; Muchmore JS; Cucchiara A; Zuhdi N J Heart Lung Transplant; 1991; 10(5 Pt 1):656-62; discussion 662-3. PubMed ID: 1659901 [TBL] [Abstract][Full Text] [Related]
10. Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease. Sarmiento E; Fernàndez-Yáñez J; Muñoz P; Palomo J; Rodríguez-Molina JJ; Bermejo J; Catalan P; Bouza E; Fernández-Cruz E; Carbone J Int Immunopharmacol; 2005 Jan; 5(1):97-101. PubMed ID: 15589466 [TBL] [Abstract][Full Text] [Related]
11. Concomitant Aspergillus and Cytomegalovirus infection in heart transplant: early diagnosis is the key to successful treatment. Tigen E; Tigen K; Karaahmet T; Odabasi Z; Korten V Exp Clin Transplant; 2009 Sep; 7(3):168-72. PubMed ID: 19715527 [TBL] [Abstract][Full Text] [Related]
12. Quiz page. Posttransplantation lymphoproliferative disorder (PTLD) involving the brain and the allograft. Tang S; Lai KN Am J Kidney Dis; 2005 Apr; 45(4):A55, e61-2. PubMed ID: 15806458 [No Abstract] [Full Text] [Related]
13. Cytomegalovirus ischemic colitis of a diabetic renal transplant recipient. Chang HR; Lian JD; Chan CH; Wong LC Clin Transplant; 2004 Feb; 18(1):100-4. PubMed ID: 15108778 [TBL] [Abstract][Full Text] [Related]
14. Prevention of cytomegalovirus disease after heart transplantation: preemptive therapy with 7 days' intravenous ganciclovir. Paniagua MJ; Crespo-Leiro MG; De la Fuente L; Tabuyo T; Mosquera I; Cañizares A; Naya C; Fariña P; Juffé A; Castro-Beiras A Transplant Proc; 2002 Feb; 34(1):69-70. PubMed ID: 11959189 [No Abstract] [Full Text] [Related]
15. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J Circulation; 2004 Dec; 110(25):3858-65. PubMed ID: 15611389 [No Abstract] [Full Text] [Related]
16. [Clinical efficacy of treating infant cytomegalovirus hepatitis with ganciclovir and impact on cytokines]. Xiong W Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Nov; 26(11):1130-2. PubMed ID: 21322282 [TBL] [Abstract][Full Text] [Related]
17. MYSS: should we alter clinical practice? Maes B; Vanrenterghem Y Lancet; 2004 Dec 4-10; 364(9450):2016-7; author reply 2017-8. PubMed ID: 15582052 [No Abstract] [Full Text] [Related]
18. Discontinuation of immunosuppressive antimetabolite for parvovirus B19-associated anemia in kidney transplant patients. Shimmura H; Tanabe K; Ishikawa N; Tokumoto T; Toda F; Toma H Transplant Proc; 2000 Nov; 32(7):1967-70. PubMed ID: 11120023 [No Abstract] [Full Text] [Related]
19. Cardiac transplantation in pediatric patients: fifteen-year experience of a single center. Groetzner J; Reichart B; Roemer U; Reichel S; Kozlik-Feldmann R; Tiete A; Sachweh J; Netz H; Daebritz S Ann Thorac Surg; 2005 Jan; 79(1):53-60; discussion 61. PubMed ID: 15620914 [TBL] [Abstract][Full Text] [Related]
20. Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients. Kovac D; Kotnik V; Kandus A Transplant Proc; 2005 Dec; 37(10):4230-4. PubMed ID: 16387086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]